The stock of x-ray digitization firm Swissray International hasbeen approved for listing on the NASDAQ stock exchange's small-capbulletin board under the symbol SRMI. Swissray, of Hitzkirch,Switzerland, is developing Add-On Bucky, a device that
The stock of x-ray digitization firm Swissray International has
been approved for listing on the NASDAQ stock exchange's small-cap
bulletin board under the symbol SRMI. Swissray, of Hitzkirch,
Switzerland, is developing Add-On Bucky, a device that retrofits
to conventional x-ray systems for x-ray digitization (SCAN 12/13/95).
Swissray's stock was trading at about $4.75 a share last week.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.